← All organizations

Saegis Pharmaceuticals

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 1, 2004

Acquired by Lundbeck on Dec 12, 2006

Timeline

1990s

Jan 1, 1999
Saegis Pharmaceuticals— Founded

2000s

Dec 12, 2006
Lundbeck— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

sgs-742

Indications

Studied for

Alzheimer Disease

Recent trials (1)

NCT00093951Lead sponsorPhase 2Apr 1, 2004

Details

Founded: Half Moon Bay, CA, US Jan 1, 1999
Last known activity: Apr 1, 2004